Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Its structure supports the development of novel agents with potential anxiolytic and anticonvulsant properties. The presence of trifluoromethyl and oxazine moieties enhances metabolic stability and blood-brain barrier penetration, making it valuable in optimizing drug candidates. Also explored in medicinal chemistry for structure-activity relationship studies due to its rigid scaffold and favorable pharmacokinetic profile.